Author

Leander Cornelis

SWITCHING INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB WAS SAFE AND SUCCESSFUL SHORT TERM IN ULCERATIVE COLITIS AND CROHN PATIENTS – A BELGIAN SINGLE CENTER EXPERIENCE
SWITCHING INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB WAS SAFE AND SUCCESSFUL SHORT TERM IN ULCERATIVE COLITIS AND CROHN PATIENTS – A BELGIAN SINGLE CENTER EXPERIENCE

Leander Cornelis  et al.

SWITCHING INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB WAS SAFE AND SUCCESSFUL SHORT TERM IN ULCERATIVE COLITIS AND CROHN PATIENTS – A BELGIAN SINGLE CENTER EXPERIENCE
SWITCHING INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB WAS SAFE AND SUCCESSFUL SHORT TERM IN ULCERATIVE COLITIS AND CROHN PATIENTS – A BELGIAN SINGLE CENTER EXPERIENCE

Item 1 - 2 / 2
1